Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Gesundheit & MedizinOne-Off1J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 79.4%
Prognostiker
3
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 2 Stunden
Veraltet21. Feb. 23, 20:25 UTC31. Dez. 27, 22:59 UTC
Trends
Regeln
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
